Table 4 |
|||
|
Performance summary of locus-region cross-validation using different feature sets. When either MP or PubMed, or both (MP + PubMed) were left out, the performance dropped significantly |
|||
|
Features |
Average rank ratio of "target" genes |
Number of times "target" genes were ranked top 5% |
Number of times "target" genes were ranked top 10% |
|
|
|||
|
All |
7.39% |
118 |
125 |
|
GO + MP + PubMed |
7.50% |
118 |
126 |
|
MP + PubMed |
7.08% |
121 |
126 |
|
Without GO |
6.84% |
117 |
123 |
|
Without Pathway |
7.66% |
118 |
124 |
|
Without Domain |
6.71% |
118 |
124 |
|
Without Interaction |
7.17% |
120 |
124 |
|
Without Expression |
7.28% |
118 |
128 |
|
Without MP |
9.77% |
110 |
117 |
|
Without Pubmed |
9.91% |
100 |
111 |
|
Without MP & Pubmed |
22.61% |
71 |
80 |
|
|
|||
|
Chen et al. BMC Bioinformatics 2007 8:392 doi:10.1186/1471-2105-8-392 |
|||